Citation 119580

MAHMOOD,N: MOORE,PS: DE TOMMASI,N: DE SIMONE,F: COLMAN,S: HAY,AJ: PIZZA,C:. (1993). INHIBITION OF HIV INFECTION BY CAFFEOYLQUINIC ACID DERIVATIVES.. 4(4)

Citation Details

Title	INHIBITION OF HIV INFECTION BY CAFFEOYLQUINIC ACID DERIVATIVES.
Authors	MAHMOOD,N: MOORE,PS: DE TOMMASI,N: DE SIMONE,F: COLMAN,S: HAY,AJ: PIZZA,C:
Year	1993
Volume	4
Issue	4

Summary

Year: 1993

Journal: Unknown

Organisms and Their Experiments (6)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTED	QUINIC ACID,3-4-5-TRI-O-CAFFEOYL:	None
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINIC ACID,3-4-5-TRI-O-CAFFEOYL:	ACTIVE
3	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINIC ACID,3-4-5-TRI-O-CAFFEOYL:	WEAK ACTIVITY
4	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINIC ACID,3-4-5-TRI-O-CAFFEOYL:	ACTIVE
5	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINIC ACID,3-4-5-TRI-O-CAFFEOYL:	ACTIVE
6	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,3-4-5-TRI-O-CAFFEOYL:	ACTIVE
7	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,3-4-5-TRI-O-CAFFEOYL:	WEAK ACTIVITY
8	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,3-4-5-TRI-O-CAFFEOYL:	INACTIVE
9	ANTIBODY BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,3-4-5-TRI-O-CAFFEOYL:	ACTIVE
10	VIRAL INFECTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,3-4-5-TRI-O-CAFFEOYL:	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTED	CHLOROGENIC ACID C,ISO:	None
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CHLOROGENIC ACID C,ISO:	ACTIVE
3	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CHLOROGENIC ACID C,ISO:	WEAK ACTIVITY
4	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CHLOROGENIC ACID C,ISO:	ACTIVE
5	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CHLOROGENIC ACID C,ISO:	ACTIVE
6	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROGENIC ACID C,ISO:	ACTIVE
7	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROGENIC ACID C,ISO:	WEAK ACTIVITY
8	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROGENIC ACID C,ISO:	ACTIVE
9	ANTIBODY BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROGENIC ACID C,ISO:	ACTIVE
10	VIRAL INFECTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROGENIC ACID C,ISO:	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTED	QUINIC ACID,3-4-5-TRI-O-GALLOYL:	None
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINIC ACID,3-4-5-TRI-O-GALLOYL:	ACTIVE
3	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINIC ACID,3-4-5-TRI-O-GALLOYL:	INACTIVE
4	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINIC ACID,3-4-5-TRI-O-GALLOYL:	INACTIVE
5	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINIC ACID,3-4-5-TRI-O-GALLOYL:	INACTIVE
6	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,3-4-5-TRI-O-GALLOYL:	ACTIVE
7	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,3-4-5-TRI-O-GALLOYL:	EQUIVOCAL
8	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINIC ACID,3-4-5-TRI-O-GALLOYL:	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTED	CAFFEIC ACID	None
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CAFFEIC ACID	EQUIVOCAL
3	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CAFFEIC ACID	EQUIVOCAL
4	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CAFFEIC ACID	INACTIVE
5	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CAFFEIC ACID	INACTIVE
6	VIRAL INFECTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID	WEAK ACTIVITY

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTED	SYNAPOIC ACID	None
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SYNAPOIC ACID	EQUIVOCAL
3	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SYNAPOIC ACID	INACTIVE
4	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SYNAPOIC ACID	INACTIVE
5	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SYNAPOIC ACID	INACTIVE
6	ANTIBODY BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SYNAPOIC ACID	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTED	ROSMARINIC ACID	None
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ROSMARINIC ACID	WEAK ACTIVITY
3	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ROSMARINIC ACID	WEAK ACTIVITY
4	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ROSMARINIC ACID	WEAK ACTIVITY
5	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ROSMARINIC ACID	WEAK ACTIVITY
6	ANTIBODY BINDING INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ROSMARINIC ACID	ACTIVE
7	VIRAL INFECTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ROSMARINIC ACID	ACTIVE

Show SPARQL Queries (1)